CD274 and gastric cancer: Evidence indicates that the chemotherapeutic agent 5-fluorouracil (5-FU) increases tumor-derived exosomal PD-L1 release via the miR-940/Cbl-b/STAT5a axis in patients with extensive-stage gastric cancer [41].